Medtronic EVP & CFO Karen Parkhill to participate in the Barclays healthcare conference

DUBLIN, March 6, 2024 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 26th annual Barclays global healthcare conference on Tuesday, March 12, 2024.

Karen Parkhill, Medtronic executive vice president and chief financial officer, will answer questions on the company beginning at 8:00 a.m. EDT (7:00 a.m. CDT).

A live webcast of the Q&A session will be available on March 12, 2024, by clicking on the Events link at http://investorrelations.medtronic.com. An archive of the Q&A session will be available on the same webpage later in the day.

Related posts:

Hummingbird Bioscience to Present Two Posters on Anti-HER3 and Anti-VISTA Antibody Therapeutics at American Association for Cancer Research (AACR) Meeting 2024 Antengene to Present Four Preclinical Abstracts at AACR 2024, Highlighting Focus on Cancer Immunology, Targeted Agents and Novel Technology Platforms Everest Medicines Announces Interim Results for First Half of 2022 Data from KN046 in Patients with metastatic NSCLC who failed first line treatment or prior EGFR-TKIs Presented at ESMO 2022

Author

GeneOnline